Tratamiento de los linfomas no hodgkinianos indolentes

Moreno Nogueira, JA; Casas Fernández de Tejerina, A; Moreno Rey, C.
Rev. clín. esp. (Ed. impr.) ; 209(2): 82-87, feb. 2009. tab
Artículo en Español | IBECS (España) | ID: ibc-73002

Documentos relacionados

  1. [Clinical analysis of 7 cases of pregnancy with non-Hodgkin lymphoma].
  2. [Epigenetic abnormalities in non-Hodgkin lymphomas].
  3. A case of non-Hodgkin lymphoma of the upper gingiva with minimal residual disease detected in cryopreserved ovarian tissue: A case report.
  4. The forgotten survivor: A comprehensive review on Non-Hodgkin lymphoma survivorship.
  5. Allogeneic stem cell transplantation and CAR-T in B-cell Non-Hodgkin Lymphoma: a two-center experience and review of the literature.
  6. Multicenter phase II study of moderate low-dose radiotherapy in indolent non-Hodgkin lymphoma: CLCG-iNHL-01 protocol.
  7. Children's Oncology Group's 2023 blueprint for research: Non-Hodgkin lymphoma.
  8. Elraglusib (formerly 9-ING-41) possesses potent anti-lymphoma properties which cannot be attributed to GSK3 inhibition.
  9. [Expression and significance of jumonji domain-containing protein 2B and hypoxia inducible factor-1α in non-Hodgkin lymphoma tissues in children].
  10. Environmental pesticide exposure and non-Hodgkin lymphoma survival: a population-based study.